Oxycellulose as mucoadhesive polymer in buccal tablets

References

• Witt J, Ramji N, Gibb R, Dunavent J, Flood J, Barnes J. (2005). Antibacterial and antiplague effects of a novel, alcohol-free oral rinse with cetylpyridinium chloride. J Contemp Pract, 6:1–10.
   PubMedGoogle Scholar
• Roberts WR, Addy M. (1981). Comparison of the in vivo and in vitro antibacterial properties of antiseptic mouthrinses containing chlorhexidine, alexidine, cetyl pyridinium chloride and hexetidine. Relevance to mode of action. J Clin Periodontol, 8, 295–310.
   PubMed Web of Science ®Google Scholar
• Addy M. (1994). Local delivery of antimicrobial agents to the oral cavity. Adv Drug Deliv Rev, 13:123–34.
   Web of Science ®Google Scholar
• Busscher HJ, White DJ, Atema-Smit J, Geertsema-Doornbusch G, de Vries J, and van der Mei HC. (2008). Surfactive and antibacterial activity of cetylpyridinium chloride formulations in vitro and in vivo. J Clin Periodontol, 35:547–54.
   PubMed Web of Science ®Google Scholar
• Ali J, Khar R, Ahuja A, Kalra R. (2002). Buccoadhesive erodible disk for treatment of oro-dental infections: design and characterisation. Int J Pharm, 283:93–103.
   Web of Science ®Google Scholar
• Nafee NA, Boraie NA, Ismail FA, Mortada LM. (2003). Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. Acta Pharm, 53:199–212.
   PubMedGoogle Scholar
• Kuna M, Rabiśková M. (2007). Mucoadhesive tablets for oral administration of ciclopiroxolamine. Ceska Slov Farm, 56:243–8.
   PubMedGoogle Scholar
• Nafee NA, Boraie NA, Ismail FA, Mortada LM. (2004). Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation. Drug Dev Ind Pharm, 30:985–93.
   PubMed Web of Science ®Google Scholar
• Gandhi RB, Robinson JR. (1994). Oral cavity as a site for bioadhesive drug delivery. Adv Drug Deliv Rev, 13:43–74.
   Web of Science ®Google Scholar
• Bruschi ML, de Freitas O. (2005). Oral bioadhesive drug delivery systems. Drug Dev Ind Pharm, 31:293–310.
   PubMed Web of Science ®Google Scholar
• Lee WJ, Park JH, Robinson JR. (2000). Bioadhesive-based dosage forms: The next generation. J Pharm Sci, 89:850–66.
   PubMed Web of Science ®Google Scholar
• Serra L, Doménech J, Peppas NA. (2009). Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents. Eur J Pharm Biopharm, 71:519–28.
   PubMed Web of Science ®Google Scholar
• Jinsong Hao KC, Heng PWS. (2003). Buccal delivery systems. Drug Dev Ind Pharm, 29:821–33.
   PubMed Web of Science ®Google Scholar
• Salamat-Miller N, Chittchang M, Johnston TP. (2005). The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev, 57:1666–91.
   PubMed Web of Science ®Google Scholar
• Ceschel GC, Bergamante V, Calabrese V, Biserni S, Ronchi C, Fini A. (2006). Design and evaluation in vitro of controlled release mucoadhesive tablets containing chlorhexidine. Drug Dev Ind Pharm, 32:53–61.
   PubMed Web of Science ®Google Scholar
• Hagesaether E, Sande SA. (2007). In vitro measurements of mucoadhesive properties of six types of pectin. Drug Dev Ind Pharm, 33:417–25.
   PubMed Web of Science ®Google Scholar
• Onishi H, Machida Y, Koyama K. (2007). Preparation and in vitro characteristics of lactoferrin-loaded chitosan microparticles. Drug Dev Ind Pharm, 33:641–7.
   PubMed Web of Science ®Google Scholar
• Surapaneni M, Das S, and Das N. (2006). Effect of excipient and processing variables on adhesive properties and release profile of pentoxifylline from mucoadhesive tablets. Drug Dev Ind Pharm, 32:377–87.
   PubMed Web of Science ®Google Scholar
• Dvorá2ková K. (2009). Drug release from oral matrix tablets containing hypromellose. Chem Listy, 103:66–72.
   Web of Science ®Google Scholar
• Schmidt R, Bogan D, Moore J. (2001). Use of oxidized cellulose as free radical scavenger. EU Patent Office, Pat No 1153618.
   Google Scholar
• Watt PW, Harvey W, Wiseman D, Light N, Saferstein L, Cini J. (2003). Use of oxidized cellulose and complexes thereof for chronic wound healing. EU Patent Office, Patent No 0918548.
   Google Scholar
• Zimnitsky DS, Yurkshtovich TL, Bychkovsky PM. (2004). Synthesis and characterization of oxidized cellulose. J Polym Sci A Polym Chem, 42:4785–91.
   Web of Science ®Google Scholar
• Delattre C, Michaud P, Elboutachfaiti R, Courtois B, Courtois J. (2006). Production of oligocellouronates by biodegradation of oxidized cellulose. Cellulose, 13:63–71.
   Web of Science ®Google Scholar
• Watt PW, Harvey W, Lorimer E, Wiseman D. (1998). Use of oxidized cellulose and complexes thereof for chronic wound healing. World Patent Office, Patent No 9800180.
   Google Scholar
• Saferstein L, Wolf S, Kamp L, Linsky C, Wiseman D. (1991). Process for preparing a neutralized oxidized cellulose product and its method of use. EU Patent Office, Patent No EP0437095.
   Google Scholar
• Sheleg SV, Korotkevich EA, Zhavrid EA, Muravskaya GV, Smeyanovich AF, Shanko YG, et al. (2002). Local chemotherapy with cisplatin-depot for glioblastoma multiforme. J Neurooncol., 60, 53–9.
   PubMed Web of Science ®Google Scholar
• Cohen EC. (1986). Microencapsulated astringent hemostatic agents and methods of use. US Patent Office, Patent No 4,597,960.
   Google Scholar
• Zhu L, Kumar V, Banker GS. (2000). Examination of oxidized cellulose as a macromolecular prodrug carrier: Preparation and characterization of an oxidized cellulose-phenylpropanolamine conjugate. Int J Pharm, 223, 35–47.
   Web of Science ®Google Scholar
• Zhu L, Kumar V, Banker GS. (2004). Examination of aqueous oxidized cellulose dispersions as a potential drug carrier: II. In vitro and in vivo evaluation of phenylpropanolamine release from microparticles and pellets. AAPS PharmSciTech, 5 (4): article 70.
   Google Scholar
• Zimnitsky DS, Yurkshtovich TL, Bychkovsky PM. (2005). Multilayer adsorption of amino acids on oxidized cellulose. J Colloid Interface Sci, 285:502–8.
   PubMed Web of Science ®Google Scholar
• Bala K, Guha SK, and Vasudevan P. (1982). p-Amino salicylic acid—oxidized cellulose system: A novel for long term drug delivery. Biomaterials, 3:113–21.
   PubMed Web of Science ®Google Scholar
• Gert EV, Torgashov VI, Zubets OV, Kaputskii FN. (2005). Preparation and properties of enterosorbents based on carboxylated microcrystalline cellulose. Cellulose, 12:517–26.
   Web of Science ®Google Scholar
• Gert EV, Torgashov VI, Zubets OV, Kapustkii FN. (2006). Combination of oxidative and hydrolytic functions of nitric acid in productions of enterosorbents based on carboxylated microcrystalline cellulose. Russ J Appl Chem Eng Tr, 79:1896–901.
   Web of Science ®Google Scholar
• Bajerová M, Gajdziok J, Dvorá2ková K, Masteiková R, and Kollár P. (2008). Polosyntetické deriváty celulosy jako základ hydrofilních gelových systému. Ceska Slov Farm, 57:63–9.
   PubMedGoogle Scholar
• Takahashi Y, Takeda C, Seto I, Kawano G, Machida Y. (2007). Formulation and evaluation of lactoferrin bioadhesive tablets. Int J Pharm, 343:220–7.
   PubMed Web of Science ®Google Scholar
• Khanna R, Agarwal SP, Ahuja A. (1996). Preparation and evaluation of bioerodible buccal tablets containing clotrimazole. Int J Pharm, 138:67–73.
   Web of Science ®Google Scholar
• Munasur AP, Pillay V, Chetty DJ, Govender T. (2006). Statistical optimisation of the mucoadhesivity and characterisation of multipolymeric propranolol matrices for buccal therapy. Int J Pharm, 323:43–51.
   PubMed Web of Science ®Google Scholar
• Duchene D, Ponchel G. (1997). Bioadhesion of solid oral dosage forms, why and how? Eur J Pharm Biopharm, 44:15–23.
   Web of Science ®Google Scholar
• Smart JD. (1993). Drug delivery using buccal-adhesive systems. Adv Drug Deliv Rev, 11:253–70.
   Web of Science ®Google Scholar
• El-Samaligy MS, Yahia SA, Basalious EH. (2004). Formulation and evaluation of diclofenac sodium buccoadhesive discs. Int J Pharm, 286:27–39.
   PubMed Web of Science ®Google Scholar
• Bettini R, Colombo P, Massimo G, Catellani PL, and Vitali T. (1994). Swelling and drug release in hydrogel matrices: polymer viscosity and matrix porosity effects. Eur J Pharm Sci, 2:213–9.
   Web of Science ®Google Scholar
• Conti S, Maggi L, Segale L, Ochoa Machiste E, Conte U, Grenier P, . (2007). Matrices containing NaCMC and HPMC: 1. Dissolution performance characterization. Int J Pharm, 333:136–42.
   PubMed Web of Science ®Google Scholar
• Rabiśková M, Chalabala M, Chalupová Z, Masteiková R, Vitková M, Gleich S. (2006). Dosage forms as aplication systems. In: Komárek P,Rabiśková M, eds. Pharmaceutics. Praha: Galén, 204–248.
   Google Scholar
• Karavas E, Georgarakis E, Bikiaris D. (2006). Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur J Pharm Biopharm, 64:115–26.
   PubMed Web of Science ®Google Scholar
• Tobyn MJ, Johnson JR, Dettmar PW. (1996). Factors affecting in vitro gastric mucoadhesion: II. Physical properties of polymers. Eur J Pharm Biopharm, 42:56–61.
   Web of Science ®Google Scholar
• Juarez H, Rico G, Villafuerte L. (2001). Influence of admixed carboxymethylcellulose on release of 4-aminopyridine from hydroxypropyl methylcellulose matrix tablets. Int J Pharm, 216:115–25.
   PubMed Web of Science ®Google Scholar
• Dow Chemical Company. (2009). Mucoasal biodhesives, company materials. http://www.dow.com [accessed February 18, 2010].
   Google Scholar
• Colorcon Limited. (2008). Using METHOCEL cellulose ethers for controlled release of drugs in hydrophilic matrix systems, company materials. http://www.colorcon.com [accessed February 18, 2010].
   Google Scholar
• Sovilj V, Petrovic L. (2007). Interaction and phase separation in the system HPMC/NaCMC/SDS. Colloid Surf A, 298:94–8.
   Web of Science ®Google Scholar
• Conti S, Maggi L, Segale L, Ochoa Machiste E, Conte U, Grenier P, . (2007). Matrices containing NaCMC and HPMC: 2. Swelling and release mechanism study. Int J Pharm, 333:143–51.
   PubMed Web of Science ®Google Scholar
• Vetchý D, Vetchá M, Rabiśková M, Gryczová E, Bartośíková L. (2007). Comparison in vitro felodipine release rate from the original versus generic product with controlled release of the drug. Medicina, 43:326–31.
   PubMedGoogle Scholar